home All News open_in_new Full Article

Bayer erhält weitere Zulassung für Milliardenmedikament Eylea

Pharma - Das Pharmaunternehmen Bayer erhält die EU-Zulassung für noch längere Behandlungsintervalle mit dem Augenmedikament Eylea.


today 6 d. ago attach_file Economics

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Other


ID: 3534037839
Add Watch Country

arrow_drop_down